Fund moves

Cellebrite Di (CLBT)Phoenix Financial Ltd. added to its stake +2M shares

Phoenix Financial Ltd. added to its stake in Cellebrite Di, per its Q2 2026 13F.

6.18M
Shares reported · +2M vs prior quarter
0.62%
Disclosed portfolio weight
$90.2M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 2, 2026InsiderCEO sold ~$1.63M of CLBT shares in the open market
  2. Jul 8, 2026InsiderCFO sold ~$683K of CLBT shares in the open market

What came next

  1. Aug 12, 2026Insider · 3 peopleInsiders: 3 sales (~$2.2M)
  2. Aug 21, 2026Insider · 2 peopleInsiders: 2 sales (~$166K)
  3. Aug 24, 2026InsiderOfficer sold ~$49K of CLBT shares in the open market
  4. Aug 25, 2026InsiderInsider sold ~$286K of CLBT shares in the open market
  5. Oct 9, 20265% stakePertento Partners LLP reported a passive stake (13G) of 5.2%
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Cellebrite Di

For Cellebrite Di, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CLBT page.

How this filing works

Other disclosures at Cellebrite Di

Everything OQRO holds on this company is on its CLBT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data